During a Case-Based Roundtable® event, Sumanta K. Pal, MD, moderated a discussion on quality of life data and experiences ...

This is the second accelerated approval the FDA has granted to Bristol Myers Squibb’s chimeric antigen receptor T-cell ...

PRESS RELEASEAB SCIENCE ANNOUNCES ISSUANCE OF A EUROPEAN PATENT FOR MASITINIB IN THE TREATMENT OF SEVERE MASTOCYTOSIS WITH PROTECTION UNTIL ...

HAMPTON ROADS, Va. — Hematologist and Oncologist Dr. Pankit Vachhani and Suki Tipp, a woman living with Indolent Systemic Mastocytosis, join Coast Live to discuss the debilitating disease ...

Indolent B-cell non-Hodgkin lymphomas (iNHLs) account for approximately 40% of all NHL cases. The majority of iNHLs are mature B-cell lymphomas, including the most common subtype of follicular ...